Skip to main content

Day: June 2, 2023

Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks

XI’AN, China, June 02, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the launch of three powder drinks to its cruciferous vegetable-based health supplement series. The new powder drinks include: broccoli seed caffeine powder drink, broccoli seed coconut powder drink, and broccoli seed green tea powder drink. Thoughtfully formulated, the combination of broccoli seed extract and BON’s proprietary prebiotic stachyose can help regulate microbiome health to improve one’s immune system and overall health. “We are thrilled to expand the line of our cruciferous vegetable-based supplement series with the announcement of the new powder drinks.”...

Continue reading

22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII

BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it will participate in the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, Los Angeles, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private one-on-one meetings. 22nd Century is scheduled to present on June 6th at 1:00 p.m. Pacific Time. A webcast of the presentation will be available on the investors section of 22nd Century’s corporate site, at www.xxiicentury.com. The company expects to discuss the expanding commercial launch of its FDA authorized VLN® reduced nicotine content...

Continue reading

eXp Realty Unites With Vesta Settlements to Provide Local Title Services in Virginia

Brokerage to launch additional title service ventures across United StateseXp Realty Unites With Vesta Settlements to Provide Local Title Services in Virginia eXp Realty Brokerage to launch additional title service ventures across United StatesBELLINGHAM, Wash., June 02, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced a strategic title and brokerage joint venture with Vesta Settlements, LLC, to bring local title expertise and personalized service to its agents in Virginia. The venture is designed to provide eXp Realty agents in Virginia with a local title partner that would streamline the home buying and selling process and offer a superior level of service. It is the first of its kind...

Continue reading

Enstar Completes Loss Portfolio Transfer With RACQ

HAMILTON, Bermuda, June 02, 2023 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) announced today that one of its wholly-owned subsidiaries has closed a previously announced Loss Portfolio Transfer agreement with RACQ Insurance Limited (“RACQ”) to reinsure 80% of RACQ’s motor vehicle compulsory third party insurance liabilities, covering accident years 2021 and prior. Under the reinsurance agreement, which is effective as of July 1, 2022, RACQ will cede net reserves of approximately AUD$ 360 million (USD$ 235 million), and Enstar’s subsidiary will provide approximately AUD$ 200 million (USD$ 130 million) of cover in excess of the ceded reserves. The amount of net loss reserves ceded, as well as the settlement and limit amounts provided in the agreement, will be adjusted for claims paid between the effective date and the closing...

Continue reading

Cognition Therapeutics Continues Investor Engagement in June with Presentations at World Medical Innovation and Longwood Healthcare Leaders Conferences

PURCHASE, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today that the Company’s president and CEO, Lisa Ricciardi will participate in two conferences designed to introduce life science innovations to investors and other stakeholders. First, Ms. Ricciardi will participate on a panel focused on advances in neuroscience during the Longwood Healthcare Leaders Spring MIT Conference, which is taking place on June 7-8, 2023 at MIT’s Koch Institute. Second, during a panel at the Mass General Brigham World Medical Innovation Forum, which is being held June 12-14, 2023 in Boston, MA, she will be discussing advancements in the treatment of CNS diseases such as Alzheimer’s disease and dementia with Lewy bodies. Details of Ms. Ricciardi’s presentation are as follows:...

Continue reading

Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Hudbay’s Plan of Arrangement with Copper Mountain and Recommend Shareholders Vote “FOR”

Hudbay Shareholders SCAN MECopper Mountain Shareholders SCAN METhe transaction makes “strategic sense” as it increases scale, diversification and could result in a valuation re-rating Have questions or need help voting? Contact Kingsdale Advisors:Hudbay Shareholders at 1-855-682-2031 (toll free in North America) Copper Mountain Shareholders / CDI holders at 1-855-682-2031 (toll free in North America) or email contactus@kingsdaleadvisors.comVisit www.HudbayPOA.com or www.CopperMountainPOA.com for more detailsTORONTO, June 02, 2023 (GLOBE NEWSWIRE) —  Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) and Copper Mountain Mining Corporation (“Copper Mountain”) (TSX: CMMC) (ASX: C6C) are pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co., LLC (“Glass Lewis”),...

Continue reading

3D Systems Confirms Submission of a Superior Proposal to Combine with Stratasys

Combination Creates Clear Pure-Play Additive Manufacturing Leader with Unmatched Scale and Highly Attractive Financial Profile in Rapidly Scaling Industry Significant Shareholder Value Creation Fueled by $100 Million of Cost Synergies Inclusive of Cost Synergies, Proposal Provides Value of Approximately $25 per Stratasys Share, a 70% Uplift for Stratasys Shareholders Proposal Delivers Certain and Immediate Value and Unparalleled Long-Term UpsideROCK HILL, S.C., June 02, 2023 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD) confirmed its submission of a proposal to combine with Stratasys (Nasdaq:SSYS) in a cash and stock merger that would convert each Stratasys share into $7.50 in cash and 1.2507 newly issued shares of 3D Systems common stock.1 The combination would create an additive manufacturing industry leader, with Stratasys...

Continue reading

Emerita Resources Corp. Announces $8,000,000 Private Placement

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, June 02, 2023 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSXV: EMO) (the “Company” or “Emerita”) is pleased to announce that it has entered into an agreement with Clarus Securities Inc. as lead agent on behalf of a syndicate of agents (collectively, the “Agents”), whereby the Agent will raise up to $8,000,000 through an offering of up to 20,000,000 units of the Company (the “Units”) to be priced at C$0.40 per Unit (the “Offering”). Each Unit is comprised of one common share in the capital of the Company (“Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to...

Continue reading

Amber Grid applied to the Prosecutor Office regarding the fittings of GIPL

AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. As part of an internal investigation and evaluation of the information, the operator of the gas transmission system Amber Grid approached the Prosecutor Office regarding some of fittings of the GIPL gas pipeline. The ongoing process has no impact on the normal operation of the GIPL pipeline. The company emphasizes that the previous and new additional tests and studies of the gas pipeline and its details confirm that the gas pipeline is technically safe and reliable. “We turned to the Prosecutor Office in order to dispel all the doubts that arose during the investigation, as this is an object of strategic importance,” says Nemunas Biknius, CEO of Amber Grid. The Prosecutor Office conducting the pre-trial investigation, in order...

Continue reading

Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer

New data emphasizes the value of MRD testing in predicting survival outcomes and informing the personalized treatment of patients with hematologic cancers clonoSEQ continues to be the MRD test of choice for biopharma companies as evidenced in over a dozen investigational studies across multiple therapeutic approaches SEATTLE, June 02, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, will be included in several oral and poster presentations investigating the clinical significance of minimal residual disease (MRD) assessment at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago, as well as the European...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.